In the first two years, classes often adjourn by noon, leaving students free to pursue independent study or extra-curricular activities.

[10] On January 29, 2021, the University of Kentucky announced a "significant partnership" between King's Daughters Medical Center in Ashland and UK HealthCare.

A major part of this agreement, which officially went into force on April 1, 2021, included King's Daughters providing training opportunities for University of Kentucky College of Medicine students.

[17] Dr. Havens' research focuses on eastern Kentucky drug users and Human Papillomavirus (HPV) outbreaks and endocarditis.

[18][19] Associate Professor Peter Akpunonu is currently performing an international study funded by the Department of Defense and Ophirex[20] observing the utility of Varespladib in crotalid envenomations.

Associate Professor with Tenure, Terry Hinds, Jr, along with Kyle Flack has a clinical trial at the University of Kentucky where we are studying obese humans and if increases in plasma bilirubin and exercise help lose weight faster.